510(k) Report

FDA applicant

Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd]

Salt Lake Ciy,, UT1 decision2021–20212 recalls

FDA records 1 decision for Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd] (Salt Lake Ciy,, UT) in 2021: 1 510(k) clearance. All are in product code MHC (Needle, Interosseous). Its devices cite 1 predicate, 0 of them its own earlier devices. 2 recalls are linked to its devices, 2 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd]’s devices, and how often a recall has named them.

FDA decisions per year

1in 2021

2021: 1
2021high 1 (2021) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

1in 2026

2022: 1, 1 Class I2026 (partial year): 1, 1 Class I
2021high 1 (2022) · low 0 (2021)2026

Class I Class II/III not classified

FIG. 1 — Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of… by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Bard Access Systems, Inc…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Bard”

FDA records each applicant name separately; these may or may not be the same firm.